Literature DB >> 2065442

Elevated plasma levels of endothelin in patients with sepsis syndrome.

E Weitzberg1, J M Lundberg, A Rudehill.   

Abstract

The levels of the recently isolated endothelial-derived peptide, endothelin, which has potent vasoconstrictor properties, were analyzed by radioimmunoassay in plasma from six patients with sepsis syndrome. For comparison endothelin levels were also measured in plasma from ten healthy volunteers. In the septic group plasma endothelin-like immunoreactivity was five-fold higher (11.3 +/- 2.8 pmol/l) compared to the volunteers (2.4 +/- 0.07 pmol/l) (P less than 0.01). Three patients had anuria and were found to have the highest plasma endothelin levels, maximally 23.8 pmol/l. In the septic group plasma endogenous norepinephrine was increased to 8.3 +/- 2.2 nmol/l, as compared to 0.98 +/- 0.09 nmol/l in healthy volunteers (P less than 0.01). The results confirm that the sympathetic nervous system is activated in the septic patient. Plasma levels of endothelin, probably emanating from damaged endothelial cells by bacterial toxins, are also elevated indicating that this peptide may be involved in vasoconstrictor responses resulting in organ failure, which so often is encountered in septicemia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2065442

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  22 in total

Review 1.  Bosentan and the endothelin system in congestive heart failure.

Authors:  S H Ellahham; V Charlon; Z Abassi; K A Calis; W K Choucair
Journal:  Clin Cardiol       Date:  2000-11       Impact factor: 2.882

2.  Posterior reversible encephalopathy syndrome in infection, sepsis, and shock.

Authors:  W S Bartynski; J F Boardman; Z R Zeigler; R K Shadduck; J Lister
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

3.  Endothelin-1 production by the canine macrophage cell line DH82: enhanced production in response to microbial challenge.

Authors:  Jeffrey N Divino; Kashmira S Chawla; Christina M da Silva; Ashley M Bjorge; Andrew Brittingham
Journal:  Vet Immunol Immunopathol       Date:  2010-02-13       Impact factor: 2.046

Review 4.  Mechanisms in acute septic cardiomyopathy: evidence from isolated myocytes.

Authors:  K Werdan; U Müller; C Reithmann; A Pfeifer; S Hallström; B Koidl; G Schlag
Journal:  Basic Res Cardiol       Date:  1991 Sep-Oct       Impact factor: 17.165

Review 5.  Endothelin-1 and its role in the pathogenesis of infectious diseases.

Authors:  Brandi D Freeman; Fabiana S Machado; Herbert B Tanowitz; Mahalia S Desruisseaux
Journal:  Life Sci       Date:  2014-04-26       Impact factor: 5.037

Review 6.  The role of the microcirculation in multiple organ dysfunction syndrome (MODS): a review and perspective.

Authors:  C J Kirkpatrick; F Bittinger; C L Klein; S Hauptmann; B Klosterhalfen
Journal:  Virchows Arch       Date:  1996-02       Impact factor: 4.064

Review 7.  Intensive care.

Authors:  S Sinclair; M Singer
Journal:  Postgrad Med J       Date:  1993-05       Impact factor: 2.401

8.  Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock.

Authors:  E Weitzberg; A Hemsén; A Rudehill; A Modin; M Wanecek; J M Lundberg
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 9.  Endothelins. A potential target for pharmacological intervention in diseases of the elderly.

Authors:  H Lévesque; N Moore; N Cailleux; V Richard; C Thuillez; H Courtois
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

10.  Endotoxemic pulmonary hypertension is largely mediated by endothelin-induced venous constriction.

Authors:  Patrik Rossi; Björn Persson; Piet J M Boels; Anders Arner; Eddie Weitzberg; Anders Oldner
Journal:  Intensive Care Med       Date:  2008-01-24       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.